⌘K

Login Start Free

Home/Filings/4/0000950170-24-139123

4//SEC Filing

SUMER JACQUELYN L 4

Accession 0000950170-24-139123

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 5:00 PM ET

Size

4.9 KB

Accession

0000950170-24-139123

Insider Transaction Report

Form 4

Period: 2024-12-18

Cullinan Therapeutics, Inc.CGEM

SUMER JACQUELYN L

Chief Legal Officer

Transactions

Sale
Common Stock
2024-12-18$11.41/sh−3,482$39,730→ 90,651 total

Footnotes (1)

[F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cullinan Therapeutics, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001844824

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 5:00 PM ET
Size: 4.9 KB

View on SEC.gov